Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 12/20 | 0.41 |
| ▸ | MAG | P20916 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15965931 | 1.00 | CD22 (0.41) | CD22MAGMEN1KMT2A | |
| SCHEMBL14823609 | 0.82 | MANBA (0.33) | CD22MAG | |
| SCHEMBL15965915 | 0.82 | MANBA (0.33) | CD22MAG | |
| SCHEMBL14823596 | 0.79 | CD22 (0.31) | CD22MAG | |
| SCHEMBL15965921 | 0.79 | CD22 (0.31) | CD22MAG | |
| SCHEMBL14811204 | 0.79 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL14823602 | 0.77 | SIGLEC7 (0.32) | CD22MAG | |
| SCHEMBL15965909 | 0.77 | SIGLEC7 (0.32) | CD22MAG | |
| SCHEMBL15966435 | 0.75 | L3MBTL1 (0.35) | CD22MAG | |
| SCHEMBL15965926 | 0.72 | CD22 (0.31) | CD22MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140234364-A1 | TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234364-A1 | TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS | FUT5, DAD1, STT3B | CD22 1149/4885MAG 102/4885MEN1 654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.